Microbot Medical Inc.MBOTNASDAQ
LOADING
|||
MBOT Revenue Growth (YoY Quarterly)•+0.00%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +40.69% | +40.33% | +21.08% | +145.76% | +192.00% |
| Weighted Average Shares Diluted Growth | +40.69% | +40.33% | +21.08% | +145.76% | +192.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -79.83% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -41.40% | -27.57% | +319.33% | +345.67% | +1469.89% |
| Book Value per Share Growth | -63.22% | -44.11% | +287.72% | +104.00% | +603.49% |
| Debt Growth | -61.63% | -51.95% | -33.65% | +0.68% | +856.38% |
| R&D Expense Growth | +27.79% | +78.81% | +27.87% | +48.13% | -43.64% |
| SG&A Expenses Growth | +33.05% | +54.16% | +28.56% | +47.35% | +116.94% |
1 / 4